Quick View
| Metric | Current Period | Same Period of Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥46.5B | ¥43.2B | +7.5% |
| Operating Income | ¥9.7B | ¥7.3B | +32.9% |
| Ordinary Income | ¥9.8B | ¥7.3B | +34.3% |
| Net Income | ¥6.8B | ¥5.0B | +36.6% |
| ROE (Annualized) | 15.4% | 11.9% | - |
Executive Summary
This earnings result reflects significant improvement in the operating margin, with profit growth exceeding revenue growth. Revenue was ¥46.5B (+7.5% YoY), Operating Income was ¥9.7B (+32.9%), Ordinary Income was ¥9.8B (+34.3%), and Net Income attributable to owners of the parent was ¥6.8B (+36.6%). The Operating Income margin increased by approximately 4pt to 20.9%, from 16.9% in the same period of the previous year, as growth in the cost of sales and SG&A expenses remained below revenue growth, resulting in strong operating leverage. The difference between Ordinary Income and Operating Income was small at ¥0.1B, indicating that profit growth was based on improved profitability in the core business rather than non-operating factors.
Factors Affecting Earnings
【Revenue】Revenue increased 7.5% YoY to ¥46.5B. Gross profit was ¥36.7B (+10.4%), exceeding revenue growth, and the gross profit margin improved to 79.1% from 78.2% in the previous year. The cost of sales remained limited to ¥9.7B (+3.4%), suggesting improved project profitability.
【Income and Expenses】SG&A expenses were ¥27.0B (+2.0%), progressing at a rate well below revenue growth, and the SG&A ratio declined from 58.2%. As a result, Operating Income was ¥9.7B (+32.9%), leading to Ordinary Income of ¥9.8B (+34.3%) and Net Income of ¥6.8B (+36.6%). The key feature is that both revenue and profits increased, with the profit growth rate substantially exceeding the revenue growth rate.
Key Financial Indicators
【Profitability】The Operating Income margin improved significantly to 20.9% (16.9% in the previous year), while the Net Income margin rose to 14.7% (11.5% in the previous year). The gross profit margin was 79.1%, a slight increase from 78.2% in the previous year.【Cash Quality】Cash and deposits were ¥45.1B, representing 63.4% of total assets. Investment partnership operating gains accounted for the majority of the ¥0.2B in non-operating income, indicating a low degree of dependence on financial income.【Investment Efficiency】Annualized ROE was 15.4% and the Equity Ratio was 83.1%; the high Net Income margin supported capital efficiency under low financial leverage.【Financial Soundness】Current assets were ¥53.2B versus current liabilities of ¥11.3B, resulting in a substantial current ratio of approximately 471%. Interest-bearing debt consisted solely of ¥2.0B in short-term borrowings, and the Debt/Capital ratio was 3.3%, indicating a conservative capital structure.
Cash Flow Analysis
Although the cash flow statement is not disclosed, funding trends can be confirmed from changes in the balance sheet. Cash and deposits increased to ¥45.1B from ¥41.9B in the previous year, accounting for more than 60% of total assets. Retained earnings were ¥48.9B, an increase of ¥2.7B from the previous year, indicating that Net Income for the period was being retained internally. Property, plant and equipment was ¥2.4B and software was ¥5.5B, both declining from the previous year, suggesting that the Company is in a phase of recovering from large-scale investments. Short-term borrowings were ¥2.0B, at the same level as the previous year, with no significant change in the funding structure. Overall, the Company continues to pursue internally funded, organic growth-oriented financial management.
Earnings Quality
The quality of profit growth can be assessed as high. Non-operating income was ¥0.2B, equivalent to approximately 0.3% of revenue, with investment partnership operating gains of ¥0.1B as the primary component; therefore, dependence on temporary factors is limited. The difference between Ordinary Income and Operating Income was only ¥0.1B, indicating that profits were derived from the core business. Comprehensive income was ¥7.1B, slightly exceeding Net Income of ¥6.8B. The difference was attributable to valuation differences on securities of ¥0.2B, indicating limited accrual-related distortion. Regarding the tax burden, income taxes and other taxes were ¥3.0B against Profit Before Tax of ¥9.8B, resulting in an effective tax rate of approximately 30.6%, a standard level.
Shareholder Returns
The Q2 dividend was ¥13.00 per share. Based on the weighted-average number of shares outstanding during the period of 17,763,383 shares, total dividends were approximately ¥2.3B, resulting in a Payout Ratio of approximately 34.1% against cumulative Net Income of ¥6.8B. Against the backdrop of substantial retained earnings of ¥48.9B, the return burden based solely on dividends remains at a restrained level. The Company holds treasury shares of ¥4.1B; however, because additional acquisitions during the period cannot be confirmed from the disclosed data, no assessment is made of the Total Return Ratio.
Risk Factors
-
Dependence on Specialized Personnel Risk: Specialized services such as IR and SR support are susceptible to the effects of personnel hiring and rising compensation costs. During the current period, the SG&A expense growth rate of +2.0% remained below the revenue growth rate of +7.5%, resulting in operating leverage. However, if personnel expenses increase at a rate exceeding revenue growth, the trend of margin improvement could reverse.
-
Demand Volatility Risk: The business is susceptible to the stock market environment, the strength of shareholder activism, and the capital policies and M&A activity of client companies. Changes in the pace of project generation could therefore become a factor contributing to revenue volatility.
-
Short-Term Debt Concentration Risk: Interest-bearing debt consists solely of ¥2.0B in short-term borrowings, with maturities concentrated in the short term. However, cash and deposits of ¥45.1B are approximately 22 times these borrowings, limiting the refinancing burden at present.
Industry Benchmark (For Reference; Compiled by the Company)
Industry Benchmark (healthcare)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 20.9% | 6.9% (3.0%–10.5%) | +14.0pt |
| Net Income Margin | 14.7% | 5.3% (2.4%–7.7%) | +9.3pt |
The Company's profitability significantly exceeds the industry median and is positioned at a high level within the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 7.5% | 8.6% (1.4%–16.0%) | −1.1pt |
The revenue growth rate is slightly below the industry median but remains within the IQR.
※Source: Compiled by the Company
Key Takeaways from the Earnings Results
-
Operating Income growth was +32.9% against revenue growth of +7.5%, and the Operating Income margin improved from 16.9% in the previous year to 20.9%. The primary factor was the emergence of operating leverage as SG&A expense growth remained below revenue growth.
-
Achieving annualized ROE of 15.4% under a conservative financial structure consisting of cash and deposits of ¥45.1B, an Equity Ratio of 83.1%, and a Debt/Capital ratio of 3.3% demonstrates the coexistence of profitability and financial safety.
-
The difference between Ordinary Income and Operating Income was only ¥0.1B, while the difference between Comprehensive Income and Net Income was also small at approximately ¥0.2B, indicating that profit growth during the period was derived from the core business with limited dependence on temporary factors.
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.
---End of Report---